Limb-Girdle Muscular Dystrophy (LGMD) New Treatment

Ayush Samiti
Ayush Samiti / Blog / 5 yrs ago /
  1

 

All limb-girdle muscular dystrophies (LGMD) show a similar distribution of muscle weakness, affecting both upper arms and legs. Frequently, the first reported symptoms are difficulty climbing stairs, standing from a squatting position, or raising arms above the head. Although muscle biopsy remains a useful tool, molecular genetic studies are now available for confirmed diagnosis. Mamsagni Rasayana-KS (MR-KS) is new ayurvedic molecule have shown promising results.

The limb-girdle muscular dystrophies are genetic disorder that progress to loss of walking ability within a few years and cause sedate disability, while others progress very gradually over many years and cause minimal disability. The usual symptoms may involve muscle weakness, apparent lack of coordination and progressive crippling, resulting in fixations (contractures) of the muscles around your joints and loss of mobility. No treatment is at present known in any system of medicine which has any definite influence upon muscular dystrophy. The absence of specific treatment for muscular dystrophy makes it all the more important to consider complementary and alternative approaches of treatment. In India, the Dystrophy boys always seek Ayurvedic help in the hope for some relief. The Ayurvedic treatment involving Rasayana group of herbo-mineral or gold based medicine, yogic support and specific Panch karma procedures have shown definite protective influence and longer survival upon muscular dystrophy. Ayurvedic specialists carefully consider this condition as adibala-pravrit Mamsa-vata-kshaya due to srotorodha. There is depletion of Mamsagni paving the way of Ama formation. It is followed by vitiation of Kapha dosha. The complex pathogenesis of LGMD manifests as first prokopa and then depletion of Vata element and is responsible for progressive wasting and necrosis of the affected muscle fibers.

Laboratory Diagnosis: It is important to recognize that laboratory testing in LGMD. Some tests, such as DNA analyses in genetic disorders and enzyme assays in the metabolic myopathies, will provide a specific diagnosis. Other tests, such as electromyography and the ischemic forearm test, suggest the type of problem but not an exact diagnosis. Creatine kinase (CK) is the single most useful laboratory study for LGMD.

Treatment: Treatment of LGMD is aimed to prolong survival and improve quality of life includes weight control to avoid obesity, Panch Karma procedures and stretching yogic exercises to encourage mobility and prevent contractures. Use of mechanical aids to help ambulation and mobility. Orthopedic surgery may be required to assist correct or prevent contractures and scoliosis. Genetic counseling is frequently helpful to patients and families to help in family-planning decision

The Mamsagni Rasayana-KS (MR-KS) is new ayurvedic molecule developed by Dr Mukesh D. Jain of AMDS India after care through clinical research of over 15 years on Neuro-Muscular Diseases at Central Medical Institute Bhilai, India. Get more information in google link below:

http://docs.google.com/Doc?id=ddwvgcng_75kx2bkd9&invite=gswp3kc

Ayurvedic Til-Mash Pinda Swedana treatment along with Rasayana herbo-mineral resources should be investigated in the light of possible influence on Sarcolemma membrane and NF?B: blockade. In this context targeted research is needed to identify safe ayurvedic herbs, Yogic techniques and Panch karma procedures to further improve complementary approach of Ayurveda. The Ayurvedic program is useful in the long term management of muscular dystrophies. There is further need of controlled studies and multi center clinical trials on a large scale with improved study design and assessment techniques.

LGMD Advice and support

Ayush Muscular Dystrophy Society India
Tel: +91 (788) 229-2358
Email: ayushmuscularsociety@gmail.com


Ayush Samiti / / 4 yrs ago
Ayush Samiti

We are in an unprecedented era of hope for therapies for
DMD based on the underlying molecular basis of the
disease. The ayurvedic approach of Rasayana therapy can act as a catalyst to improve care for patients with DMD worldwide.

Mamsagni Rasayana 500 mg is found effective to stop further deterioration of muscles. Patient can notice effect within 6-8 weeks. The medicine should be used for 6-8 month. It is taken orally, has the potential to address the underlying degenerative Vata derangement causing destruction of the muscle fibres. It gives better results if used along with TMP ayurvedic therapy and Yogic support.

Mamsagni Rasayana does not alter the patient’s genetic code or introduce genetic materials into the body. It is natural product developed and being clinically used by AMDS India for Care through ayurvedic research project since 1995. This natural dietary medicament is safe for human consumption.